Suchergebnisse - "Cleary, James M"

PubPharm (140)

1

RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Singh, H. | Sahgal, P. | Kapner, K. | +39

2

Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer

enthalten in: Nature | 2024

von Wasko, U. | Jiang, J. | Dalton, T. | +63

3

Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting

enthalten in: NPJ precision oncology | 2024

von Prosz, A. | Sahgal, P. | Huffman, B. | +20

4

FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma

enthalten in: Journal of hepatology | 2024

von Xu, L. | Zhang, Y. | Lin, Z. | +28

5

Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Corcoran, R. | Do, K. | Kim, J. | +28

6

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma : 3-Year Follow-Up of the Phase III CheckMate 649 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Janjigian, Y. | Ajani, J. | Moehler, M. | +23

7

The phase I/II eNRGy trial : Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

enthalten in: Future oncology (London, England) | 2024

von Kim, D. | Schram, A. | Hollebecque, A. | +15

8

NCI10066 : a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma

enthalten in: British journal of cancer | 2024

von Cecchini, M. | Cleary, J. | Shyr, Y. | +20

9

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma : analysis of a phase II clinical trial and a cohort of long-term responders

enthalten in: Journal for immunotherapy of cancer | 2024

von Huffman, B. | Singh, H. | Ali, L. | +35

10

Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signatures

enthalten in: bioRxiv.org | 2024

von Gulhan, D. | Viswanadham, V. | Muyas, F. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]